Depatuxizumab MMAE

Product Description: Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising an anti EGFR monoclonal antibody (Depatuxizumab) and the cytotoxic agent Monomethyl auristatin E (MMAE). Depatuxizumab inhibits the growth of xenograft models of mutant EGFRvIII and wild-type EGFR[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Reilly EB, et al. Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody. Mol Cancer Ther. 2015 May;14(5):1141-51.

Molecular Weight: 148000 (average)

Compound Purity: 99.73

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Antibody-Drug Conjugates (ADCs)

• Artikelnummer: MEXHY-156712-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-156712-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK